A Safety Study of SGN-CD48A in Patients With Multiple Myeloma
Clinical trial NCT03379584 · TERMINATED
Trial details
- NCT number
- NCT03379584
- Sponsor
- Seagen Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-20
- Primary completion
- 2019-08-23
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.